DeepSight Technology, a diagnostic device company, has unveiled its NeedleVue LiteCart Ultrasound System. The system, which is pending FDA authorization, aims to improve ultrasound-guided medical procedures.
The NeedleVue system features tiny sensors at the instrument tips, providing real-time visualization of needles, guidewires, and catheters. The technology is self-calibrating, requires no advanced setup, operates with contrast agents, and is unaffected by temperature and magnetic fields.
DeepSight Technology specializes in developing diagnostic imaging solutions and needle guidance systems, leveraging proprietary sensing technology and AI to enhance ultrasound performance. The company claims its NeedleVue system could potentially be applied across various medical specialties, particularly in abdominal procedures such as biopsies.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.